Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

奇洛先 - NMPA Drug Approval Details

Approvals/NMPA/Lomefloxacin Hydrochloride Tablets

Approved

化学药品

Lomefloxacin Hydrochloride Tablets

北大医药股份有限公司🇨🇳 National Medical Products Administration

Approval Date: Aug 4, 2020
Approval ID: 7LeaeFQAD9J
Company: 北大医药股份有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeFQAD9J
Approval Number: 国药准字H20000715
Generic Name: 盐酸洛美沙星片
Generic Name En: Lomefloxacin Hydrochloride Tablets
Trade Name: 奇洛先
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 0.1g(按C17H19F2N3O3计)
Reg Date: 2020-08-04
Company Name: 北大医药股份有限公司
Production Company Name: 北大医药股份有限公司
Production Company Address: 重庆市北碚区水土镇方正大道21号附1号
Company Detail Path: /organization/pku-healthcare-corp-ltd
Production Company Detail Path: /organization/pku-healthcare-corp-ltd

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Aug 4, 2020

Approval ID

7LeaeFQAD9J

Type

化学药品

Back to NMPA Approvals